• Login as Editor
    View Item 
    •   Yeshiva Academic Institutional Repository
    • Albert Einstein College of Medicine (AECOM)
    • Albert Einstein College of Medicine: Doctoral Dissertations
    • View Item
    •   Yeshiva Academic Institutional Repository
    • Albert Einstein College of Medicine (AECOM)
    • Albert Einstein College of Medicine: Doctoral Dissertations
    • View Item
    JavaScript is disabled for your browser. Some features of this site may not work without it.

    THE ROLE OF REPLICATION-COMPETENT VIRUS IN FRIEND VIRUS DISEASE

    Thumbnail
    Date
    1987
    Author
    JONES, KATHRYN SUZANNE
    Metadata
    Show full item record
    Abstract
    Friend virus complex (FV), which consists of the replication-competent Friend murine leukemia virus (FMuLV) and the replication-defective spleen focus-forming virus (SFFV), induces a multistage erythroleukemia. We have examined the role of the replication-competent helper virus in the early and late stages of FV disease by replacing FMuLV, the native helper, with Akv, the endogenous ecotropic MuLV of AKR mice. SFFV{dollar}\sb{lcub}\rm P{rcub}{dollar}/FRE, an established fibroblast line nonproductively infected with the polycythemic strain of SFFV, was superinfected with FMuLV or with Akv. Although supernatants from these cells contained equal amounts of helper virus, supernatants from Akv-infected SFFV{dollar}\sb{lcub}\rm P{rcub}{dollar}/FRE cells show 100-5000-fold less activity than those from FMuLV-infected cells with respect to spleen focus induction in vivo. Since virions isolated from these two supernatants contain similar amounts of genomic RNA, it does not appear that the difference is due to a relative inability of Akv to package SFFV. Although FMuLV- and Akv-rescued SFFV are equally infectious in a mouse fibroblast cell line (NIH3T3), FMuLV-rescued SFFV is far more efficient in causing a productive infection in vitro of BFU-e cells, the target cell of FV disease. In vivo studies showed that FMuLV injected with helper-free SFFV induces 50-500 fold more splenic foci than Akv coinjected with helper-free SFFV.;Helper virus also affects mortality rates that reflect the late stage of the disease. When FMuLV- or Akv-rescued SFFV was injected into NIH Swiss mice at dosage levels adjusted to give equal numbers of spleen foci, all of the mice receiving FMuLV-rescued SFFV developed splenomegaly and died, whereas none of the mice receiving Akv-rescued SFFV died or developed detectable splenomegaly. When FMuLV was coinjected with Akv-rescued SFFV, the mortality rate rose from 0% to 100%. Similarly, although injection of helper-free SFFV alone did not induce any mortality, coinjection of helper-free SFFV with FMuLV or with a high titer of Akv resulted in 100% mortality. Thus, helper virus used to rescue SFFV plays at least a quantitatively important role in the early stage of FV disease and a crucial role in the late stage of the disease in vivo.
    Permanent Link(s)
    https://yulib002.mc.yu.edu/login?url=http://gateway.proquest.com/openurl?url_ver=Z39.88-2004&rft_val_fmt=info:ofi/fmt:kev:mtx:dissertation&res_dat=xri:pqm&rft_dat=xri:pqdiss:8719441
    https://hdl.handle.net/20.500.12202/3156
    Collections
    • Albert Einstein College of Medicine: Doctoral Dissertations [1674]

    Yeshiva University Libraries copyright © 2021  DuraSpace
    YAIR Self-Deposit | YAIR User's Guide | Take Down Policy | Contact Us
    Yeshiva University
     

     

    Browse

    AllCommunities & CollectionsBy Issue DateAuthorsTitlesSubjectsThis CollectionBy Issue DateAuthorsTitlesSubjects

    My Account

    Login as Editor

    Statistics

    View Usage Statistics

    Yeshiva University Libraries copyright © 2021  DuraSpace
    YAIR Self-Deposit | YAIR User's Guide | Take Down Policy | Contact Us
    Yeshiva University